Wajeeha Aiman, MD

Nishtarian | IMG | ResearchLearner | HemeOnc Fellow at Roswell Park

[OncoDaily @oncodaily]

📌 Community Oncology Global Congress 2026 | Day 2

The Second Day of the Community Oncology Global Congress 2026 continued with a focus on gastrointestinal and breast cancers, exploring biomarker testing, modern systemic treatment, multidisciplinary care, and the priorities shaping cancer care across different healthcare settings.

The program first turned to colorectal and upper gastrointestinal cancers in community oncology. Moderated by Josue J. Bravo Espinoza , Jeanine Ewing, PharmD, BCOP discussed the importance of essential biomarker testing in colorectal and upper GI cancers.

Martina Carullo then explored modern systemic treatment approaches, while Darshil Shah, MD, MPH Shah focused on building multidisciplinary care for upper and lower GI cancers.

The focus then shifted to breast cancer in community oncology and optimising endocrine and personalised treatment approaches. Moderated by Wajeeha Aiman, Seema Harichand-Herdt discussed priorities in early and metastatic breast cancer, while Houda Belfekih explored the role of biomarker-guided approaches in breast cancer care. Sana Al Sukhun, MD., MSc. FASCO. then addressed breast cancer priorities across different healthcare settings, bringing further attention to the practical challenges of improving access and outcomes for patients.

Together, these sessions are highlighting the importance of bringing modern diagnostics, personalised treatment, and multidisciplinary expertise closer to patients - while adapting cancer care to the realities of community oncology and diverse healthcare systems around the world.

@martweetings @SanaAlSukhun @Wajeheme

🔴 Live sessions available here: https://t.co/YcEm7SATgf

🔗 Learn more about Community Oncology Global Congress 2026: https://t.co/fTVBPkJ8a0

[Roswell Park Hematology/Oncology Fellowship @RoswellHemOnc]

🌟 Kicking off the new academic year by welcoming our new Hematology/Oncology fellows!

Great energy as PGY-4, PGY-5, and PGY-6 came together to connect and gear up for an impactful year ahead.

#HemeOnc #Fellowship #MedTwitter @RoswellPark

[Rafeh Naqash, MD, FASCO @thenasheffect]

Fantastic survey with real wold challenges that need to be discussed and highlighted for #IMG parents in the U.S with limited support systems @IMG_Oncologists @ASCO @VivekSubbiah @ADesaiMD @CharuAggarwalMD @ASCOTECAG @Noha_Soror

[Jame Abraham, MD, FACP @jamecancerdoc]

Please join me in congratulating @FaizAnwerMD1, who is appointed as full Professor @CleClinicLCM @ClevelandClinic @cwru ! A true mentor who believes in paying it forward by helping many students, residents and fellows @ccfhemonc and around the country! @CCF_IMCHIEFS !

[Arya Roy @royaryam]

Planning your career after fellowship? Our article on @ASCO connection explores the pros & cons of academia, community & hybrid practices! A practical guide to help fellows make informed decisions! @MatthewKurianMD @rajatthawani @ASCOTECAG @OhioStateMedOnc @HemOncFellows

[Tulsi Jose, MD @drtulsijose]

Great article written by colleagues @royaryam
@MatthewKurianMD
@rajatthawani on crafting a life after fellowship training. https://t.co/BK8dm0eBVE

[Wajeeha Aiman, MD @Wajeheme]

@MmrSahar @ashar_ali_ @RoswellHemOnc @FaizAnwerMD1 @DrHKantarjian Thank you so much @MmrSahar ❤️

[Wajeeha Aiman, MD @Wajeheme]

Congratulations hubs @ashar_ali_ !!
I am thrilled and excited to start HemeOnc fellowship with you in 2025 but a little far @RoswellHemOnc . Hard work pays off. Thanks to our mentors @FaizAnwerMD1 @DrHKantarjian

[AHN Hematology/Oncology Fellowship @AHNhemeonc]

We are extremely excited to introduce our fellowship class of 2028. Can’t wait to start working with all of them!

[Wajeeha Aiman, MD @Wajeheme]

@FaizAnwerMD1 @ashar_ali_ @RoswellHemOnc @DrHKantarjian Thanks alot Dr. @FaizAnwerMD1

[Wajeeha Aiman, MD @Wajeheme]

@ZunairahShah @RoswellHemOnc @Jacobs_Med_UB @RoswellPark @HemOncFellows Thank you so much♥️

[Roswell Park Hematology/Oncology Fellowship @RoswellHemOnc]

We’re excited to welcome our @Jacobs_Med_UB - @RoswellPark HemOnc fellowship class of 2027!

Congratulations to everyone 👏 👏
@HemOncFellows

[Wajeeha Aiman, MD @Wajeheme]

The World CML Day theme emphasizes the importance of inclusivity and comprehensive care for all patients, ensuring that no one is left behind in the pursuit of cures and treatments. Appreciate your work @GCC_Cortes, @icmlf
@SocietyofHemOnc

[Jorge Cortes MD @jorgecortesmd]

On this World CML Day we celebrate our patients reminding us that we should leave no patient behind. We have made progress but much work yet to be done to fulfill the dream for all. @GACancerCenter @icmlf https://t.co/yae8GVl39r

[Hem-Onc Fellows Network @HemOncFellows]

✍️Mark your calendar for our next upcoming space‼️

Fellowship Application; The Program Director Perspective, with Dr. Rami Manochakian, Heme/onc Fellowship PD at Mayo Clinic FL❗️

📅 Wednesday, 21st August 2024
⏰ 7 pm EST
Moderator: @Noha_Soror
🌟Speaker: @RManochakian

[Arya Roy @royaryam]

Excited to share that I received Robert Winn CDA @WinnAwards! Deeply grateful for the mentorship from @DrGattiMays @OhioStateMedOnc & support from @hmcarthur & @gandhi_shipra. Big thanks to @quirogad @CloneTracker StuthiPerimbeti @OSUCCC_James @RoswellPark @ASCOTECAG @StoverLab

[Sam Brondfield, MD, MAEd, FASCO @s_brond]

Excited for this! Thanks @MedNewsWeek and @YLeyfman for this platform to chat about careers in #meded! @UCSFCancer @UCSF @UCSFMedicine

[Wajeeha Aiman, MD @Wajeheme]

@Mukarram461 @AASLDFoundation @LauDaryl @AASLDtweets @DrQuinnCapers4 @LiverFellow Congratulations well deserved 👏 👏

[mukarram jamat ali @Mukarram461]

Honored to receive the 2024 @AASLDFoundation Emerging Liver Scholar award.

Grateful @LauDaryl for her support and invaluable mentorship.

@AASLDFoundation @AASLDtweets
@DrQuinnCapers4 @LiverFellow

[Wajeeha Aiman, MD @Wajeheme]

A comprehensive meta-analysis of TKIs, particularly Ponatinib with Blinatumomab, revealed promising response rates and survival. This study provides valuable insights in Ph+ALL with @DrHKantarjian. ( https://t.co/HdnFevJqiF)

[Hagop Kantarjian,MD @DrHKantarjian]

Chemo-free regimens (TKIs-blinatumomab) highly effective in Ph+ALL; may replace intensive chemoRx and allo SCT in most such patients in the future.
Clinical Lymphoma, Myeloma and Leukemia
https://t.co/T0gSPy7F2m
@NitinJainMD @NicholasShortMD @MDAndersonNews
#leusm

[Tennis Channel @TennisChannel]

This is a MUST WATCH. 😭

Watch highlights from @rogerfederer’s Dartmouth Commencement speech.

(via @dartmouth)

[Wajeeha Aiman, MD @Wajeheme]

I'm already feeling nostalgic for ASCO, and this just made my day! 0:26 second! @ASCO #ASCO24 #IMG_Oncologists #Womeninoncology

[ASCO @ASCO]

Conversations sparked. Connections made. More than 45,000 attendees came together at #ASCO24 to explore the art & science of oncology and left inspired to change the future of cancer care. Thanks to all who joined us!

Save the date for #ASCO25: May 30–June 3, 2025